Bausch + Lomb Corporation has announced European CE Mark approval for SeeLyra™. SeeLyra™ is the company’s next-generation femtosecond laser platform. Bausch + Lomb is a leading global eye health company. The company focuses on helping people see better to live better. SeeLyra™ provides surgeons with precision and control during laser-assisted surgical preparation. The platform supports premium cataract, LASIK flap, and corneal therapeutic surgeries.
At the same time, the system supports efficient workflows in modern operating rooms. Its compact design also addresses the growing space limitations within operating environments. The platform combines advanced technology with flexible operating capabilities. Therefore, surgeons can use its features while maintaining efficient surgical workflows. SeeLyra™ also introduces live swept source OCT technology. This feature provides real-time depth visualization throughout surgical procedures.
As a result, surgeons can achieve greater visibility during laser-assisted preparation. The system also supports controlled positioning during critical surgical steps.
“Building on over 15 years of experience in the femtocataract laser market, our goal was to deliver a platform that provides both enhanced functionality and greater flexibility to the OR,” said Luc Bonnefoy, president, Surgical, Bausch + Lomb. “SeeLyra delivers, helping surgeons achieve the precise preparation and controlled conditions necessary to unlock the full potential of premium cataract surgery without compromising on space or efficiency.”
SeeLyra™ Brings Precision to Laser-Assisted Surgery
SeeLyra™ includes integrated tools designed to support accuracy and surgical control. Its live swept source OCT offers real-time depth visualization during procedures. The technology can help reduce variability during the docking process. It also enables precise positioning of laser cuts. Furthermore, surgeons can maintain visual control during laser application. These capabilities support greater precision during laser-assisted surgical preparation.
SeeLyra™ also retains important features from VICTUS™, Bausch + Lomb’s previous-generation femtosecond platform. The system includes an intuitive user interface designed to simplify setup. The platform also supports adaptability across multiple surgical procedures. These procedures include cataract surgery, LASIK flap procedures, and corneal therapeutic treatments.
So SeeLyra™ combines familiar functionality with next-gen capabilities. This can help a surgeon maintain efficiency across workflows for different procedures. The design of the platform also meets the practical needs of modern operating rooms. SeeLyra™ was created by Bausch + Lomb for space efficiency and mobility.
Compact Design Enables Modern Operating Rooms
SeeLyra™ is a space-efficient solution for space-constrained ORs. There is no fixed patient bed on the platform. Instead, it is designed to be positioned easily in different operating room environments. The system also can be used with existing bed setups. This design facilitates movement and positioning of the SeeLyra™ by medical teams. Hospitals can therefore customize the platform according to their current operating room configurations.
The absence of a fixed bed also supports patient comfort. Patients do not need to switch beds between different procedures. In addition, SeeLyra™ includes an articulating swing arm. This feature allows surgeons to choose their preferred orientation during surgery. The platform therefore supports both surgical flexibility and workflow efficiency. These features can help operating rooms manage procedures more effectively.
“Premium surgery success begins with precise surgical preparation of the eye,” said José Manuel Larrosa, MD, University of Zaragoza, Spain. “SeeLyra will help me to achieve this consistently on my terms, while fitting seamlessly and efficiently into our OR space and workflow.”
The platform’s flexible configuration supports the needs of modern surgical environments. Moreover, its compact structure can help address operating room space limitations.
Bausch + Lomb Plans European SeeLyra™ Availability
Bausch + Lomb plans to make SeeLyra™ available in Europe on a limited basis. The company expects availability to increase during 2027. Meanwhile, Bausch + Lomb is pursuing regulatory approvals for SeeLyra™ in markets worldwide. The United States remains among the markets included in this process. However, indications and approvals may differ between countries. Regulatory authorities will determine availability according to individual market requirements.
The European CE Mark approval represents an important step for the platform. It allows Bausch + Lomb to begin introducing SeeLyra™ in selected European markets. The company continues to build on its experience in femtocataract laser technology. That experience spans more than 15 years in the market. SeeLyra™ extends this experience into a new generation of femtosecond laser technology. The platform combines precision, visualization, mobility, and workflow flexibility.
Live Swept Source OCT technology allows surgeons to visualize depth in real time. At the same time, it is designed compactly to meet the practical needs of an operating room. The platform also supports multiple procedures in ophthalmic surgery. These include premium cataract surgery, LASIK flap preparation and corneal therapeutic treatments. Bausch + Lomb continues to seek regulatory approvals worldwide as availability grows. And the company is preparing for broader market access in the wake of the European approval.
SeeLyra™ adds a flexible femtosecond laser platform to Bausch + Lomb’s surgical portfolio. Design is about precision, control, efficiency and adaptability. The company expects the platform will enable modern workflows in the area of ophthalmic surgery. It is also designed to give surgeons more latitude in laser-assisted eye procedures.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
